A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALOUR)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Justin Salciccioli, MD
Upstream Bio
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
102 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fundacion Cidea
CABA, Argentina, Argentina
- Instituto de Medicina Respiratoria, Imer/ Instituto Médico Damic
Córdoba, Córdoba Province, Argentina
- Centro de Medicina Respiratoria
Concepción del Uruguay, Entre Ríos Province, Argentina
- Fundacion Scherbovsky
Mendoza, Mendoza Province, Argentina
- Investigaciones En Patologias Respiratorias
San Miguel de Tucumán, Tucumán Province, Argentina
- Care: Centro de Alergia Y Enfermedades Respiratorias
Buenos Aires, Argentina
- Investigaciones En Alergias Y Enfermedades Respiratorias-Inaer
Buenos Aires, Argentina
- Centro Medico Dharma
Mendoza, Argentina
- Insares
Mendoza, Argentina
- Office of Hector H. Altieri Md
San Miguel de Tucumán, Argentina
- Instituto Especialidades de la Salud Rosario
Santa Fe, Argentina
- Mhat "rahila Angelova" Pernik
Pernik, Pernik, Bulgaria
- Ambulatory for Specialized Outpatient Medical Care - Individual Practice - Dr. Nikolay Evgeniev Ruse Ltd
Rousse, Ruse, Bulgaria
- Mc Convex/dcc Convex
Sofia, Sofia, Bulgaria
- Medical Center Excelsior (todor Popov)
Sofia, Sofia, Bulgaria
- Medical Center New Rehabilitation Center Eood
Stara Zagora, Stara Zagora, Bulgaria
- Mc Zdrave 1
Kozloduy, Vratsa, Bulgaria
- Medical Center Hera Eood
Sofia, Bulgaria
- Medical Center Pulmovizhyn
Sofia, Bulgaria
- Dynamic Drug Advancement
Ajax, Ontario, Canada
- Fundacion Medica San Cristobal
Santiago, Santiago Metropolitan, Chile
- Cimer
Ñuñoa, Santiago Metropolitan, Chile
- Sociedad Medica Sy G Limitada
Providencia, Santiago Metropolitana, Chile
- Estudios Clínicos de Enfermedades Respiratorias E Inmunológicas (cieri)
Valparaíso, Valparaiso, Chile
- Plicni Stredisko Teplice S.R.O
Teplice, Czechia
- Me Clinical Respiratory Research Hamburg Gmbh
Hamburg, Free and Hanseatic City of Hamburg, Germany
- Rcms/lungenpraxis Hohenzollerndamm
Berlin, Germany, Germany
- Ikf Pneumologie Frankfurt, Clinical Research Center Respiratory Diseases
Hessen, Germany, Germany
- Pois Sachsen Gmbh
Leipzig, Germany, Germany
- Kppk Studienzentrum
Bendorf, Germany
- Ikf Pneumologie Gmbh & Co. Kg
Mainz, Germany
- Uoc Pneumologia Aou Renato Dulbecco
Catanzaro, Catanzaro, Italy
- Tokyo-Eki Center-Building Clinic
Tokyo, Chuo-ku, Japan
- Oji General Hospital
Hokkaido, Hokkaido, Japan
- Kishiwada City Hospital
Osaka, Japan, Japan
- Osaka Habikino Medical Center
Osaka, Japan, Japan
- National Hospital Organization Ibarakihigashi National Hospital
Ibaraki, Osaka, Japan
- Osaka Metropolitan University Hospital
Osaka, Osaka, Japan
- Fukuwa Clinic
Tokyo, Tokyo, Japan
- All-Med Specjalistyczna Opieka Medyczna. Medyczny Instytut Badawczy Marek Jutel
Wroclaw, Dolnoslaskie Voivodeship, Poland
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 May 2025
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 14 May 2026
- Registered enrollment
- 396
- Registry id
- NCT06966479
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.